Lastet 50

Lastet 50


لاستتيت 50
Chemotherapeutics and Drugs Affecting Immunoresponse
category: use to Immune system ،
concentration: 50mg

what medicine Lastet 50؟

Action etoposide is inhibit of DNA synthesis resulting in arrest of cell cycle. At low Doses etoposide inhibits cells from entering cell cycle. At high Doses cells entering mitosis are lysed.
Indication Small cell lung cancer. Acute monocytic and myelomonocytic leukaemias. Hodgkin's disease. NonHodgkins lymphoma. Testicular tumours.
Dosage:Adults : Inj. 50-100 mg/m2/daily for 5 days (infuse over 30-60 mins.); then 3-4 weeks treatment free; small cell lung cancer 35mg/m2/day for 4 days. Not recommended for Children: : Oral 100-200/m2/daily on days 1 to 51 then 3-4 weeks treatment free; take on empty stomach.

what scientific name Lastet 50؟

what form Lastet 50؟

Capsule

what company Lastet 50؟

Nippon Kayako co.,Japan

what price Lastet 50؟

350 EGP

what company Lastet 50؟

Nippon Kayako co.,Japan

what company Lastet 50؟

Nippon Kayako co.,Japan

Action etoposide is inhibit of DNA synthesis resulting in arrest of cell cycle. At low Doses etoposide inhibits cells from entering cell cycle. At high Doses cells entering mitosis are lysed.
Indication Small cell lung cancer. Acute monocytic and myelomonocytic leukaemias. Hodgkin's disease. NonHodgkins lymphoma. Testicular tumours.
Dosage:Adults : Inj. 50-100 mg/m2/daily for 5 days (infuse over 30-60 mins.); then 3-4 weeks treatment free; small cell lung cancer 35mg/m2/day for 4 days. Not recommended for Children: : Oral 100-200/m2/daily on days 1 to 51 then 3-4 weeks treatment free; take on empty stomach.


Note: All the provided information about this drug does not substitute for consulting a doctor.

Related tags

Related medicines